The e4Risk^®is a non-genetic, cost-effective, and highly reliable method to detect the presence of the protein ApoE4 in human blood plasma by turbidimetry, using high-throughput chemistry analyzers.

e4Risk^®is a turbidimetry-based assay with excellent performance in the context of the hospital/clinical settings (100% sensitivity and 99% specificity).

e4Risk^®is a product with CE Marking. The process of obtaining the FDA approval is currently ongoing.

*Test based on patent nº EP 3274725 (European patent granted): “Method for apolipoprotein detection”